Max Zinter
Overview
Explore the profile of Max Zinter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
MAngale P, Lemieux A, Liu Y, Wang S, Zinter M, Alegre G, et al.
PLoS Biol
. 2025 Feb;
23(2):e3002983.
PMID: 39964983
Transposons are parasitic genome elements that can also serve as raw material for the evolution of new cellular functions. However, how retrotransposons are selected and domesticated by host organisms to...
2.
Maksoud S, Schweiger M, Tabet E, Xiao T, Hokayem J, Zinter M, et al.
Mol Neurobiol
. 2024 Aug;
62(2):2617-2625.
PMID: 39138760
Glioblastoma (GBM) is a highly aggressive brain cancer with a low survival rate, prompting the exploration of novel therapeutic strategies. Immune checkpoint inhibitors have shown promise in cancer treatment but...
3.
Klenowski P, Zhao-Shea R, Freels T, Molas S, Zinter M, MAngale P, et al.
Sci Adv
. 2023 Dec;
9(49):eadh9620.
PMID: 38055830
Stress coping involves innate and active motivational behaviors that reduce anxiety under stressful situations. However, the neuronal bases directly linking stress, anxiety, and motivation are largely unknown. Here, we show...
4.
Prabhakar S, Cheah P, Zhang X, Zinter M, Gianatasio M, Hudry E, et al.
Mol Ther Methods Clin Dev
. 2019 Sep;
15:18-26.
PMID: 31534984
Tuberous sclerosis complex (TSC) is a tumor suppressor syndrome caused by mutations in or encoding hamartin and tuberin, respectively. These proteins act as a complex that inhibits mammalian target of...
5.
da Hora C, Pinkham K, Carvalho L, Zinter M, Tabet E, Nakano I, et al.
Cell Death Discov
. 2019 Jun;
5:103.
PMID: 31240130
[This corrects the article DOI: 10.1038/s41420-019-0155-9.].
6.
Zaborowski M, Lee K, Na Y, Sammarco A, Zhang X, Iwanicki M, et al.
Cell Rep
. 2019 Apr;
27(1):255-268.e6.
PMID: 30943406
Analysis of cancer-derived extracellular vesicles (EVs) in biofluids potentially provides a source of disease biomarkers. At present there is no procedure to systematically identify which antigens should be targeted to...
7.
Erel-Akbaba G, Carvalho L, Tian T, Zinter M, Akbaba H, Obeid P, et al.
ACS Nano
. 2019 Mar;
13(4):4028-4040.
PMID: 30916923
Targeted therapy against the programmed cell death ligand-1 (PD-L1) blockade holds considerable promise for the treatment of different tumor types; however, little effect has been observed against gliomas thus far....
8.
da Hora C, Pinkham K, Carvalho L, Zinter M, Tabet E, Nakano I, et al.
Cell Death Discov
. 2019 Mar;
5:72.
PMID: 30854231
Glioblastoma is an incurable and highly aggressive brain tumor. Understanding therapeutic resistance and survival mechanisms driving this tumor type is key to finding effective therapies. Smac mimetics (SM) emerged as...
9.
Carvalho L, Teng J, Fleming R, Tabet E, Zinter M, de Melo Reis R, et al.
J Natl Cancer Inst
. 2018 Sep;
111(3):283-291.
PMID: 30257000
Background: The olfactory ensheathing cells (OECs) migrate from the peripheral nervous system to the central nervous system (CNS), a critical process for the development of the olfactory system and axonal...